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Abstract mLIM3, a member of the LIM homeobox family, was
recently demonstrated to be critical for proliferation and
differentiation of the pituitary cell lineage. Using a pool of
degenerate oligonucleotides we determined the DNA sequence
ANNAGGAAA(T/C)GA(C/G)AA as the set preferentially
recognized by mLIM3. A nearly identical sequence is found in
the prolactin (PRL) promoter, within a 15-mer stretch from
nucleotides (nts) 3218 to 3204 which is highly conserved
between human, rat, and bovine. In order to test the hypothesis of
a transcriptional effect of mLIM3 on the prolactin promoter,
stable transfectants of mLIM3 cDNA in AtT20 tumor cells
revealed that PRL mRNA expression was induced in 3 separate
stable clones. Gel retardation experiments performed using
nuclear extracts isolated from one of the AtT20/mLIM3 stable
transfectants revealed affinity towards the 15-mer element of the
PRL promoter. From these results, we propose that the PRL
promoter element (nts 3218 to 3204) could be functional in vivo.
Finally, we demonstrate that in AtT20 cells prolactin mRNA
expression is not induced by the Pit-1/GHF-1 pathway and that
growth hormone mRNA is not detected concomitantly with
prolactin. We conclude that mLIM3 may play a key role in
inducing PRL gene expression in lactotrophs by binding to a
conserved motif close to a Pit-1/GHF-1 site within the proximal
PRL promoter.
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1. Introduction
Five distinct cell types which di¡er by the expression of
speci¢c trophic hormone genes emerge from the Rathke
pouch during organogenesis, giving rise to the di¡erent cell
populations of the anterior pituitary [1]. Progressive di¡eren-
tiation of the ¢ve cell lineages is dependent on the sequential
induction of transcription factors such as Pit-1/GHF-1 [1^4].
The mouse homeobox-containing mLIM3 [5,6], also known as
P-Lim [7] or Lhx3 [8], is a new member of this LIM-HD
family and the fate of all pre-motoneurons depends on the
combined action of four LIM-HD proteins, including
mLIM3 [9]. The strongest expression of mLIM3 transcript is
observed in the anterior (AP) and intermediate (IP) pituitary
lobes and was ¢rst detected on embryonic day 11 persisting
into adulthood [5]. Within pituitary cell lines, somatolacto-
troph GH3 and GH4C1, as well as gonadotroph K-T3-1, ex-
press high levels of mLIM3 transcripts, while low expression
is detected in the corticotroph AtT20 cells [5]. Consistent with
these observations, targeted disruption of the mLIM3 gene
[10] recently revealed that homozygous mLIM3 (3/3) mice
display dramatic e¡ects on pituitary di¡erentiation and
growth. Indeed, these mice lack both the AP and IP, with
all the anterior pituitary lineages being completely absent,
except for some corticotrophs. Thus, mLIM3 appears to be
a very critical early gene whose expression is associated with
pituitary organogenesis. In addition to mLIM3 (Lhx3), a
closely related gene called Lhx4 was also reported to deter-
mine the formation of the pituitary gland in mice, and togeth-
er these two genes regulate proliferation and di¡erentiation of
pituitary-speci¢c cell lineages [11].
In an e¡ort to identify mLIM3-regulated genes expressed in
the anterior pituitary, we ¢rst determined the DNA consensus
sequence to which this protein binds. Next, since the proximal
promoter region of the prolactin gene (PRL) contains this
motif, we investigated the possibility that mLIM3 could reg-
ulate PRL expression. Corticotroph AtT20 cells which do not
endogenously transcribe PRL, were stably transfected with
mLIM3 cDNA. The resultant mLIM3-expressing cells exhib-
ited a detectable PRL mRNA expression, while no PRL tran-
scription is detectable in control cells. Moreover, we show
that the induction of PRL transcription in AtT20 cells does
not require Pit-1/GHF-1. These data suggest a particular role
of mLIM3 in relation to PRL expression in lactotroph pitui-
tary cells and constitute a step in the elucidation of the mo-
lecular basis that underlie mLIM3 action during the early
stages of pituitary di¡erentiation.
2. Materials and methods
2.1. Antibodies and Western blotting
A chimeric GST-LIM construct was obtained by inserting the cod-
ing cDNA of mLIM3 [5] in phase with GST in a pGEX-2T expression
vector (Pharmacia). An antibody against the mLIM3 protein was
raised in rabbits against a synthetic peptide corresponding to amino
acids 299^317 [5]. The anti-phosphothreonine antibody was kindly
donated by Dr. X. Prusner (McGill University). The pGEX-LIM
vector was used to prepare a fusion protein in DH5K bacterial cells,
following induction with 0.3 mM IPTG. Western blot analysis of
SDS-PAGE-fractionated proteins probed for mLIM3 immunoreactiv-
ity was achieved using an ECL kit (Boehringer Mannheim).
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2.2. Ampli¢cation/selection of a consensus sequence
A degenerate double stranded 68-bp oligonucleotide was designed
in order to determine the consensus binding sequence of mLIM3 [12]:
5P-GACAGTTGTTGTCTTCCTACTAGCTGCAG-NNNNNNTAA-
NNNNNNN-CTCGAGTGGGCGTAGTACTTCAT-3P. Both 5P (29
bp) and 3P (23 bp) ends contain non-degenerate sequences used as
primers for PCR. The 16-bp core was degenerate in 13 positions,
with a TAA anchor at its center. In each round of selection, GST-
LIM protein was incubated with the 5P-end labeled 68-bp sequence
and the oligonucleotides bound to the protein were separated from the
free ones by electrophoretic mobility shift assay (EMSA) (see Section
2.3). The bands detected by autoradiography were cut, and ampli¢ed
separately by PCR after extraction of the DNA from the acrylamide.
PCR was carried out for 30 cycles using 1-min denaturation at 94‡C,
2-min annealing at 62‡C, 1-min extension at 72‡C. One Wl of the
ampli¢cation mixture was directly used as a template for the next
round of puri¢cation by EMSA. The set of DNA obtained after the
last step of puri¢cation was directly sequenced. Two parallel experi-
ments were performed, in which either the upper band or the lower
band of the shifted complex was systematically cut and its DNA
ampli¢ed.
2.3. Electro-mobility shift assay (EMSA)
Three pmoles of double stranded template were labeled 30 min at
37‡C with [Q-32P]ATP and T4 polynucleotide kinase. GST-LIM or
nuclear extracts were incubated 30 min at room temperature in 18
Wl of a reaction mixture containing 10 mmol/l HEPES (pH 7.8),
1 mmol/l Na2HPO4 (pH 7.2), 0.1 mmol/l EDTA, 50 mmol/l KCl,
4 mmol/l MgCl2, 4 mmol/l spermidine, 2.5% glycerol in the presence
of 20 000 cpm of labeled template. The protein-DNA complexes were
analyzed by non-denaturing electrophoresis through 4.5% polyacryla-
mide gels, run in 0.25U Tris borate EDTA. The following double
stranded oligonucleotides were used either for PRL promoter study:
4P/Lim : 5P-TTCTCTCATTTCCTTTTGCTGTAATTAATCAAAA-
TCCTTCC-3P ; 4P : 5P-TTCTCTCATTTCCTTTTGCTG-3P ; 4Pmut :
5P-TTCTCTCATTTCCTTTTGCTGGCCCGAATCAAAATCCTTC-
C-3P (mutation underlined). Nuclear extracts were prepared exactly
following a protocol previously described [13].
2.4. Stable transfection of AtT20 cells with mLIM3
mLIM3 was inserted into a pRH expression vector (a gift from Dr.
T. Reudelhuber, IRCM). 50 Wg of pRH-mLIM3 vector and 5 Wg of
the Neo-resistant RcCMV vector were used to transfect 107 con£uent
AtT20 cells using lipofectin. After 48 h, the cells were selected for
resistance using 0.5 mg/ml G418. Individual clones were tested for
mLIM3 expression by biosynthetic analysis of [35S]methionine radio-
labeled cells extracted with RIPA lysis bu¡er [14]. Immunoprecipitates
of radiolabeled proteins were resolved by SDS-PAGE on a 10% T,
2.7% C polyacrylamide gel in 0.1% SDS.
3. Results
3.1. Determination of the DNA consensus sequence recognized
by mLIM3
Western blot analysis of the GST-LIM fusion protein puri-
¢ed on a glutathione-agarose column using an antiserum
raised against a C-terminal sequence of GST-LIM is shown
in Fig. 1A. Two main bands were observed with the major
form migrating with an apparent mass of 75 kDa, as expected
for the fusion protein, while the upper one (83 kDa) could be
a post-transitionally modi¢ed form, possibly involving a phos-
phorylation event (Girardin et al., unpublished data).
In order to identify the preferred DNA sequence recognized
by mLIM3 a double stranded 68-bp oligonucleotide was de-
signed (see Section 2), in which the central core was degener-
ate whereas the ends contained speci¢c sequences allowing
ampli¢cation by PCR. Since in most of the reported cases
homeodomains recognize a motif containing a TAA sequence
[12], a TAA anchor was placed at the center of the degenerate
16-mer core. We used this oligonucleotide in a selection/am-
pli¢cation experiment as described [15], except that after PCR
ampli¢cation the selection was achieved by EMSA. Following
4 rounds of ampli¢cation/selection, we extracted and puri¢ed
two enriched bands containing pools of DNA sequences in-
teracting with GST-LIM, representing di¡erentially migrating
complexes (Fig. 1B). The increase in speci¢city was gauged at
each step by the progressive loss of competition with the un-
labeled degenerate 68-bp oligonucleotide (data not shown).
Moreover, these two DNA pools interact speci¢cally with
the GST-LIM protein by the degenerate core of the probe,
since no interaction could be detected using the double-
stranded non-degenerate ends (23 bp and 29 bp) as individual
probes for EMSA (not shown).
The two eluted pairs of DNA pools obtained after the
fourth round of ampli¢cation (Fig. 1B) were used separately
as templates for a PCR-driven manual sequencing. The DNA
sequence corresponding to the upper pool is shown in Fig. 1C.
A similar result was obtained using the lower pool (data not
shown). Because of the presence of the TAA anchor, the con-
sensus sequence is directly visualized by comparing the inten-
sities of the 4 bases for each position around the TAA core
(Fig. 1C). Surprisingly, approximately half of the sequences
harbor a G instead of a T in the TAA core. This observation
is not an artifact of the PCR-driven sequencing since analysis
of 12 individual clones revealed that half of them contain a
GAA in their middle (data not shown). Two explanations can
be provided for this observation: the oligonucleotide synthesis
was not perfect and in the pool some G bases were added
instead of T; alternatively, a G mutation might have occurred
during the PCR reactions. In each case, however, the ratio G/
T would be expected to be very low, in contrast to the ob-
served ratio of 1 which indicates that the selection steps fa-
vored GAA far more than TAA. Interestingly, some sequence
positions preceding the G/TAA core exhibit similar intensities
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Fig. 1. Determination of the DNA consensus sequence recognized
by mLIM3. A: Analysis of the two procaryotic GST-fusion proteins
by Western blotting using an anti GST-LIM antibody. B: A 68-bp
partially degenerated double stranded oligonucleotide was designed
and used as a probe in a puri¢cation/selection assay carried out by
EMSA. The migration positions of the two DNA-containing bands
representing speci¢c interactions with GST-LIM are indicated for
each of the four rounds of PCR amplication. C: Sequence autora-
diogram of the mixture of 68-bp oligonucleotides obtained after
4 rounds of puri¢cation of the upper DNA band. The oligonucleo-
tide of 29 bases was used as a radioactive primer in a PCR-driven
sequencing. At each position, the base most frequently present is in-
dicated. The last C nucleotide in the 3P end is the ¢rst base outside
of the degenerate region in the 23-bp conserved motif.
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for each of the 4 bases, suggesting that these positions are not
critical for binding. Although the sequence following the G/
TAA is relatively easy to deduce, in some positions we ob-
served an excess of two bases relative to the two others. Con-
sistent with this analysis, although we could read a AN-
NAG(G/T)AAA(T/C)GA(C/G)AA sequence (Fig. 1C), the
above arguments led us to propose the following 15-mer
DNA consensus sequence: ANNAGGAAA(T/C)GA(C/G)
AA. Alignment of the consensus sequence presented in Fig.
1C with those found in the EMBL gene bank revealed an
identical 14-mer sequence within the 5P end of the prolactin
promoter (nts 3205 to 3218), in a highly conserved segment
of the rat, human and bovine sequences, suggestive of a se-
lective pressure towards this small stretch of the PRL pro-
moter [16]. We did not ¢nd such a homologous sequence in
other pituitary promoters.
3.2. mLIM3 induces endogenous PRL expression in
AtT20 cells
In order to test the hypothesis of a transcriptional e¡ect of
mLIM3 on the prolactin promoter, we generated stable trans-
fectants in the corticotroph AtT20 cells, which have been
chosen on the basis of: (i) their low endogenous expression
of mLIM3 [5]; (ii) the absence of endogenous PRL expres-
sion; and (iii) the fact that in mLIM3 knockout mice some
corticotroph cells survived [10]. Positive clones resistant to
G418 were tested for mLIM3 expression following an
[35S]methionine pulse of 4 h and immunoprecipitation using
the anti-mLIM3 antiserum as compared to a control normal
rabbit serum (NRS). Using such a selection, we were able to
isolate three stable clones which overexpress mLIM3, with
clones 1 and 6 exhibiting the highest expression (Fig. 2),
and clone 2 being a lower expressor (not shown).
Northern blot analysis was used to measure the expression
of several genes in transfected AtT20 cells overexpressing
mLIM3 as compared to control AtT20 cells transfected with
the vector alone (Fig. 3). First, the expression of POMC was
examined, since AtT20 cells endogenously express this precur-
sor. We note that both mLIM3-transfected cells and control
cells express similar levels of POMC mRNA (Fig. 3A), sug-
gesting that mLIM3 has no signi¢cant e¡ect on the expression
of POMC. Second, based on the reported in vitro interaction
of mLIM3 with the promoter of the K-subunit of LH, FSH
and TSH [7], we tested the e¡ect of the stable transfection on
the expression of the K-subunit (K-GSU) in AtT20 cells. Using
a rat pituitary extract as a positive control for the probe, the
data did not reveal an induction of the K-subunit mRNA in
our clones (Fig. 3B). Similarly, no induction of GH was ob-
served in the mLIM3-transfectants (Fig. 3C), even though
expression of mLIM3 is detected in GH-containing cells of
the mouse pituitary [5].
Using a PRL probe we were able to detect a strong induc-
tion of mRNA expression in the highest expressor of mLIM3
(clone 6 (C-6), see Fig. 2), whereas no PRL could be detected
in control cells (Fig. 3D). However, we note that the level of
induced PRL is lower than that observed using equivalent
amounts of total RNA isolated from mouse anterior pituitary
(Fig. 3E). This may explain our inability to detect the PRL
protein from AtT20/mLIM3 cells extracts using a radioimmu-
noassay ranging in sensitivity from 5 to 40 ng/ml (not shown).
In order to assess whether this activation results from a direct
interaction with the PRL promoter or from an indirect cas-
cade, we tested the possible expression of Pit-1/GHF-1 in the
transfected cells, using a rat pituitary extract as a positive
control (Fig. 3F). No induction could be detected, even with
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Fig. 3. The PRL gene is induced in AtT20/mLIM3 cells. Total
RNA extracts of AtT20 or AtT20/mLIM3 clone 6 (C-6) were used
for Northern blotting experiments using di¡erent cRNA probes and
distinct but equivalent blots in each case (A^D, F and G). One Wg
of total RNA extracts from adult rat anterior pituitary (AP) were
loaded as a positive control for the probe. The PRL gene induction
is also observed using total RNA extracts of two other AtT20/
mLIM3 clones (C-1 and C-2) (E). Autoradiograms were quanti¢ed
by densitometry and normalized for loading control with an 18S
probe (G).
Fig. 2. AtT20/mLIM3 stable transfectant analysis on three separate
clones. After stable transfection of mLIM3 in AtT20 cells, three
separate clones (1, 2 and 6) were analyzed for the presence of the
mLIM3 protein by immunoprecipitation of the [35S]methionine la-
beled cellular proteins obtained following a 4-h pulse. While we ob-
tained immunoreactive mLIM3 with clones 1, 2 and 6, we only
show the data with clones 1 and 6 which express the highest level
of mLIM3. As control for the speci¢city of the immunoprecipitation
we also show the results obtained using normal rabbit serum
(NRS). The speci¢c mLIM3 band is indicated by an arrow.
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much longer exposure of the ¢lm, suggesting that if the
mLIM3 induction on the PRL promoter is indirect, it does
not act through the Pit-1/GHF-1 pathway.
3.3. mLIM3 binds in vitro to a sequence of the PRL promoter
We noted that the PRL region suggested to interact with
mLIM3 is within 10 bp 5P to a Pit-1/GHF-1 binding site,
known as the proximal 4P site [16]. Interestingly, Bach et al.
have shown that mLIM3 is able to bind directly Pit-1/GHF-1
by its LIM domains [7], suggesting that Pit-1/GHF-1 could be
a co-factor necessary for the suppression of the inhibitory
e¡ect of the LIM domains of mLIM3, in a model similar to
that reported for other LIM family members [17].
In order to con¢rm that this PRL promoter sequence binds
to native mLIM3, an EMSA was done using an rPRL oligo-
nucleotide (nts 3181 to 3222) encompassing the rat Pit-1/
GHF-1 4P sequence [16] and the proposed mLIM3 site [4P/
Lim]. Thus, addition of increasing amounts of nuclear extracts
from either AtT20 or AtT20/mLIM3 (C-6) cells to 32P-labeled
double stranded 4P/LIM revealed a complex which is espe-
cially evident in AtT20/mLIM3 (Fig. 4A, lane 9). In contrast,
only a very weak complex was observed when equivalent
amounts of nuclear extracts obtained from control AtT20
cells were used (Fig. 4A, lane 5). The very low endogenous
level of mLIM3 expression in AtT20 cells [5] is likely to be
responsible for this interaction. In order to con¢rm the pres-
ence of mLIM3 in the low mobility complex observed, a
supershift experiment was achieved using the mLIM3 anti-
body (Fig. 4B). Noticeably, at the 1:100 dilution of the
mLIM3 antibody most of the complex was shifted close to
the top of the gel, indicating that mLIM3 was indeed present
in the complex.
Demonstration that the PRL 4P site, located 10 bp 3P of the
mLIM3 site, was not involved in the observed DNA binding,
was achieved by the use of two other double stranded oligo-
nucleotides, i.e. a mutated PRL 4P Pit-1 binding site [4Pmut],
and one in which this site is deleted [4P]. The two oligonu-
cleotides gave the same result as the original [4P/LIM], reveal-
ing that in vitro the interaction of mLIM3 on the PRL pro-
moter does not require the 4P site (Fig. 5).
4. Discussion
The aim of this study was to investigate how mLIM3 could
mediate its e¡ect during pituitary organogenesis, since this
protein has been shown to be crucial for the development
and di¡erentiation of this tissue [10,11]. This is especially
needed since the study of mLIM3 null animals revealed that
the elaboration of a de¢nitive Rathke’s pouch is directed by
either mLIM3 (Lhx3) or Lhx4, and that subsequent organ fate
commitment is regulated solely by mLIM3, an event not re-
placeable by Lhx4 [11]. In accordance with our detection of
mLIM3 in both the nucleus and cytosol of vaccinia virus
infected cells (Marcinkiewicz, M. and Seidah, N.G., unpub-
lished data) it was quite plausible that this protein is indeed a
transcription factor. Accordingly, it was necessary to charac-
terize the direct DNA binding activity of mLIM3, and to
identify the DNA consensus sequence necessary for its opti-
mum binding.
Investigation of the DNA sequence recognized by mLIM3
led to the determination of a 15-bp consensus sequence (Fig.
1C). It is noteworthy that the ¢rst 14 nucleotides of the de-
duced 15-mer consensus sequence found for optimal mLIM3-
DNA binding are: (i) located on the proximal PRL promoter,
(ii) highly conserved between rat, human and bovine, and (iii)
10 bp away from the 5P end of the fully conserved PRL 4P site
known to bind Pit-1/GHF-1 [16]. Several groups have re-
ported in vitro protection studies of this region with various
nuclear extracts, including those from a GC lactotroph/soma-
totroph cell line which expresses mLIM3 [7]. It was recently
proposed that the (nts 3217 to 3209) element was necessary
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Fig. 5. The 4P site is not involved in mLIM3 binding to the 4P/
LIM element. Three sets of radioactive probes were incubated in
the absence (lanes 1, 3, 5) or presence (lanes 2, 4, 6) of a combina-
tion of 10 pg of GST-LIM and 1 ng of AtT20/mLIM3 nuclear ex-
tracts. In lanes 7^15, the Lim/4P radioactive probe was competed
with an excess (10-, 20-, 100-fold) of each of the three non-radioac-
tive oligonucleotides 4P/LIM, 4P, and 4Pmut.
Fig. 4. The GST-LIM protein speci¢cally interacts with the PRL
promoter in vitro. A: [4P/Lim] was used as a probe either without
protein extract (lane 1); with increasing amounts (10, 50, 100 pg or
1 ng) of AtT20 nuclear extracts (lanes 2^5); or with increasing
amounts (10, 50, 100 pg or 1 ng) of AtT20/mLIM3 nuclear extracts
(lanes 6^9). B: mLIM3 antibody was added at di¡erent dilutions to
a mixture of 32P-labeled [4P/Lim] probe and 1 ng of AtT20/mLIM3
nuclear extracts. The migration position of the complex (mLIM3/
Ab) on the DNA probe is indicated. Final dilutions of the antibody
are 1:100, 1:1000, 1:5000. The upper non-speci¢c band observed in
all lanes represents precipitated viscous DNA in each well.
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for Ets-1 mediated activation of the PRL gene by the Ras/Raf
pathway [18]. Since this activation depends on Pit-1/GHF-1, it
was proposed that the (nts 3217 to 3190) element encom-
passing the Pit-1/GHF-1 site is a functional Ras response
element. Could mLIM3 and Ets-1 compete for the same site
on the PRL promoter, either during development or in the
adult pituitary? An answer to this question must await future
studies demonstrating the co-localization of Ets-1 and mLIM3
during embryogenesis and the proof that Ets1 binds to the 14-
mer recognized by mLIM3. As the results of mLIM3 null
mice [10,11] suggest that this protein controls the expression
of several pituitary genes, we were surprised to ¢nd the 14-mer
consensus sequence only in the PRL promoter and not in
other mammalian gene regulatory elements. Therefore, it is
possible that a shorter minimal DNA-binding consensus se-
quence lies within the 14-mer that we found. Indeed, Bach et
al. [19] recently de¢ned an mLIM3 DNA-binding site in the
K-GSU promoter region, and described the association on
DNA of mLIM3 with Otx family members. This element con-
tains the same GAAAT sequence that we found in the center
of our consensus sequence. We propose that the 15-mer con-
sensus sequence is preferred if mLIM3 associates alone on
DNA, although a shorter sequence could be su⁄cient if the
DNA-binding speci¢city is enhanced by a co-factor such as
Otx.
Considering the partner-induced-binding hypothesis, and
consistent with the results of Bach et al. [7], showing that
mLIM3 and Pit-1/GHF-1 directly interact through a LIM-
POU domains contact, we tested the hypothesis that Pit-1/
GHF-1 could be the partner in mLIM3 binding to the PRL
promoter in cell lines. For this purpose, we selected AtT20
cells which endogenously do not express Pit-1/GHF-1 [2], and
obtained three stable transfectants expressing variable levels
of mLIM3 protein. Northern blots of these stable transfec-
tants revealed the absence of Pit-1/GHF-1 mRNA, thus elim-
inating the possibility that mLIM3 could induce the transcrip-
tion of this factor. The ultimate demonstration that Pit-1/
GHF-1 is not involved in mLIM3-induced PRL transcription
came from the use of two double stranded oligonucleotides,
4Pmut and 4P which carry a mutation in or a deletion of the
4P site, respectively. None of these modi¢cations altered the
DNA-binding a⁄nity of mLIM3 (Fig. 5). It must be empha-
sized that our experiments cannot exclude that mLIM3 could
interact on the PRL promoter in association with other pro-
teins, as was proposed for other members of the LIM family
[20]. The present results do not contradict the model proposed
by Bach et al. [7] of a direct interaction between mLIM3 and
Pit-1/GHF-1 which could occur in pituitary somatolacto-
trophs, but rather suggest an alternate combination of pro-
teins in a cell line that does not express Pit-1/GHF-1. It must
be noted that in our stable transfectants, even though the
mRNA levels of PRL are easily detectable, they are lower
than those found in the anterior pituitary (AP) extracts
(Fig. 3E). This may provide an explanation for our inability
to detect the PRL protein in our stable transfectants by a
speci¢c radioimmunoassay sensitive between 5 and 40 ng/ml.
Furthermore, since Pit-1/GHF-1 not only activates the PRL
gene but also enhances the positioning of the transcription
initiation complex at the correct start site [21^23], its absence
from AtT20 cells (Fig. 3F) may also contribute to the non-
translatability of the PRL mRNA in these cells.
Interestingly, Agulnick et al. [24] recently isolated a new
LIM-domains binding protein, Ldb1, demonstrating a specif-
icity for LIM-HD or LMO proteins, especially for mLIM3.
Independently, another group reported the characterization of
two mLIM3-interacting proteins, CLIM-1 and CLIM-2 (iden-
ti¢ed as Ldb1) which recognize the LIM domain of mLIM3
[19]. The spatial and temporal expression patterns of CLIM-1
and CLIM-2 precisely overlap those of mLIM3 and P-OTX/
Ptx1, another protein of the Otx class of transcription factors
detected very early during pituitary organogenesis [19]. More-
over, Bach et al. demonstrated the involvement of CLIM-1
and CLIM-2 as trans-activating factors in the synergestic ac-
tivation of the K-GSU promoter by mLIM3 and P-OTX/Ptx1.
It is noteworthy that P-OTX/Ptx1 is expressed in AtT20 cells
[19], and therefore could account for the observed induction
of the PRL gene transcription.
The e¡ect described here on the PRL promoter accounts for
one of the expected multiple activities of mLIM3 in the ante-
rior pituitary. Indeed, analysis of homozygous mLIM3 (3/3)
mice revealed dramatically impaired growth and di¡erentia-
tion in the Rathke’s pouch [10,11]. Our data show that in the
adult mouse anterior pituitary, mLIM3 mRNA expression
can be detected within the ¢ve endocrine cell types [5], sug-
gesting that mLIM3 can participate in the di¡erentiation
process and/or maintenance of the di¡erentiated states of
the ¢ve cell lineages of the anterior pituitary, in agreement
with the genetic knockout data [11]. The results presented
here show that a stable transfection of mLIM3 in a cortico-
troph pituitary cell line that expresses very low endogenous
levels of mLIM3 [5] is su⁄cient to induce PRL mRNA ex-
pression. Since AtT20 cells do not express PRL (Fig. 3D), we
presume that the level of endogenous mLIM3 is too low to
allow for PRL expression, and only upon overexpression con-
ditions can we observe the induction of PRL mRNA. In con-
trast, high levels of mLIM3 mRNA in the gonadotroph cells
KT3 [5] are not su⁄cient to induce PRL transcription. This
suggests that one or more partner(s) of mLIM3 in AtT20 cells
(Fig. 4) are absent from KT3 cells. Alternatively, it is possible
that the lack of Pit-1/GHF-1 in AtT20 cells displaces the PRL
transcription starting point from the +1 position to the alter-
nate 327 position, since it has been reported that Pit-1/GHF-
1 enhance the positioning of the transcription initiation com-
plex at position +1 [21^23]. The 327 starting point represents
a non-pituitary site for PRL initiation of transcription. This
di¡erent transcript could have altered stability or be less e⁄-
ciently translated, explaining why we cannot detect PRL in
our experiments.
The complex comprising mLIM3 and its putative partner is
likely to be centered around the 4P/LIM site (nts 3181 to
3222) on the PRL promoter. Computer data bank searches
did not detect such a site elsewhere even within the evolu-
tionary closely related GH gene. Crenshaw et al. [25] showed
that the proximal PRL promoter (which contains the nts
3181 to 3222) is su⁄cient to restrict PRL expression to the
lactotroph subset. What may then be the factor(s) involved in
this cell-speci¢c expression of PRL? Since the PRL and GH
proximal promoters contain 4 and 3 Pit-1/GHF-1 sites, re-
spectively, the single transcription factor Pit-1/GHF-1 which
is expressed in both somatotrophs and lactotrophs [2,3] may
not be su⁄cient to induce a cell-restricted GH and PRL ex-
pression. It is therefore possible that in combination with an
unde¢ned partner(s), mLIM3 is critical for the expression of
PRL mRNA in cells where the GH gene is silent.
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In conclusion, the data presented in this work open up new
avenues in our understanding of the complex interplay be-
tween transcription factors involved in the regulation of the
cell-speci¢c expression of anterior pituitary hormones, and
suggest a functional role for mLIM3 in the induction of
PRL transcription.
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